We are live on ! Find out more
MCO

MAK Capital One Portfolio holdings

AUM $714M
1-Year Est. Return 68.07%
This Fund
S&P 500
This Quarter Est. Return
-31.26%
1 Year Est. Return
+68.07%
3 Year Est. Return
+199.63%
5 Year Est. Return
+307.07%
10 Year Est. Return
+2,541.72%
AUM
$185M
AUM Growth
-$121M
Cap. Flow
-$12.8M
Cap. Flow %
-6.95%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
2
Reduced
2
Closed
1

Top Buys

Rank Stock Value
1
ACHN
Achillion Pharmaceuticals
ACHN
+$9.17M
2
YTRA icon
Yatra Online
YTRA
+$8.77M
3
GBT
Global Blood Therapeutics, Inc.
GBT
+$3.6M
4
MR
Montage Resources Corporation Common Stock
MR
+$1.99M

Top Sells

Rank Stock Value
1
SKY icon
Champion Homes
SKY
+$25.4M
2
PTCT icon
PTC Therapeutics
PTCT
+$10.4M
3
MXWL
Maxwell Technologies Inc
MXWL
+$523K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 48.3%
2 Technology 41.04%
3 Healthcare 6.61%
4 Industrials 3.06%
5 Energy 1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKY icon
1
Champion Homes
SKY
$4.9B
$81.4M 44.08%
5,539,759
-1,150,000
-17% -$25.4M
AGYS icon
2
Agilysys
AGYS
$3.32B
$75.8M 41.04%
5,284,648
– –
ACHN
3
DELISTED
Achillion Pharmaceuticals
ACHN
$8.26M 4.47%
5,191,600
+3,245,493
+167% +$9.17M
YTRA icon
4
Yatra Online
YTRA
$64M
$7.79M 4.22%
1,938,559
+1,822,230
+1,566% +$8.77M
MXWL
5
DELISTED
Maxwell Technologies Inc
MXWL
$5.64M 3.06%
2,725,992
-193,182
-7% -$523K
GBT
6
DELISTED
Global Blood Therapeutics, Inc.
GBT
$3.94M 2.14%
+96,040
New +$3.6M
MR
7
DELISTED
Montage Resources Corporation Common Stock
MR
$1.84M 1%
+116,736
New +$1.99M
PTCT icon
8
PTC Therapeutics
PTCT
$5.85B
– –
-221,723
Closed -$10.4M

Similar funds

SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
OL
Optas LLC Austin, Texas $714M AUM 38.25% 1-Year Est. Return
LWM
LJI Wealth Management Indianapolis, Indiana $714M AUM 21.51% 1-Year Est. Return
HA
Huntleigh Advisors St. Louis, Missouri $714M AUM 62.24% 1-Year Est. Return
TC
Teilinger Capital Houston, Texas $714M AUM 11.06% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $715M AUM 24.33% 1-Year Est. Return
ADIC
Abu Dhabi Investment Council Abu Dhabi, United Arab Emirates $715M AUM
ZAM
Zevin Asset Management Boston, Massachusetts $713M AUM 19.82% 1-Year Est. Return

MAK Capital One's Q4 2018 Portfolio in Review

As of Q4 2018, MAK Capital One held 8 positions worth $185M, down 40% from $306M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MAK Capital One withdrew a net $12.8M in Q4 2018, closing 1 position and reducing 2 holdings. Its most notable exit was PTC Therapeutics, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 48% of assets, down from 63% a quarter earlier, followed by Technology and Healthcare.

Against the trend, MAK Capital One opened a new position in Global Blood Therapeutics, Inc. worth $3.94M.

  • MAK Capital One's largest Q4 2018 buy was Global Blood Therapeutics, Inc.: 96,040 shares worth $3.94M.
  • MAK Capital One added most to Achillion Pharmaceuticals in Q4 2018, an estimated $9.17M increase.
  • MAK Capital One's biggest Q4 2018 reduction was Champion Homes, cutting an estimated $25.4M.
  • MAK Capital One fully exited PTC Therapeutics in Q4 2018, selling an estimated $10.4M.
  • MAK Capital One's ten largest holdings make up 100% of its $185M portfolio in Q4 2018.
  • MAK Capital One opened 2 new positions and closed 1 in Q4 2018.
  • MAK Capital One's portfolio value fell 40% quarter-over-quarter to $185M.

Based on MAK Capital One's 13F filing for Q4 2018, filed 14 Feb 2019.